(Q34529820)
Statements
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers (English)
Richard B Stead
John Lambert
Dawie Wessels
Julie S Iwashita
Kerstin K Leuther
Peter J Schatz
Douglas M Okamoto
Robert Naso
Anne-Marie Duliege